Join the Whole Body Health Pilot Program
Launching 8 March – Open for sign-up NOW!
14-Day Money-Back Guarantee
Early Bird Price: $795.00
Ebbeling CB, Bielak L, Lakin PR, et al. Energy Requirement Is Higher During Weight-Loss Maintenance in Adults Consuming a Low- Compared with High-Carbohydrate Diet. J Nutr. 2020;150(8):2009-2015. doi:10.1093/jn/nxaa150
Zhang S, Wu P, Tian Y, et al. Gut Microbiota Serves a Predictable Outcome of Short-Term Low-Carbohydrate Diet (LCD) Intervention for Patients with Obesity. Microbiology Spectrum. 0(0):e00223-21. doi:10.1128/Spectrum.00223-21
A recent paper by Cooper et al. (2023) comments on the long term effects of being in nutritional ketosis for women. They found sustained ketosis showed no adverse health effects and metabolic flexibility was preserved.
The second paper in this series (2024) looked at biomarkers associated with aging, with no adverse effects.
For weight loss and reproductive health, see ‘Female Reproductive Health’ further down in the listing.
Ciaffi, J. et al. (2023) ‘Efficacy, safety and tolerability of very low-calorie ketogenic diet in obese women with fibromyalgia: a pilot interventional study’, Frontiers in Nutrition, 10. Available at: https://www.frontiersin.org/articles/10.3389/fnut.2023.1219321 .
There have now been a number of reviews on this topic. A recent (07/2021) narrative review paper from Wheatley et al is an excellent overview of the literature, the remaining areas of controversy, and practical recommendations. A recent review of meta-analyses and clinical trials from Dyńka et al contains useful summary tables of trials. In addition, this paper from Brown et al focuses on options for remission (08/2021).
Lan, J. et al. (2024) ‘Efficacy of different dietary carbohydrate intake for glycaemic control and insulin resistance in type 2 diabetes: A systematic review and dose-response meta-analysis’, Asia Pacific Journal of Clinical Nutrition [Preprint]. Available at: https://doi.org/10.6133/apjcn.202412/PP.0003.
Tian, W. et al. (2025) ‘The effects of low-carbohydrate diet on glucose and lipid metabolism in overweight or obese patients with T2DM: a meta-analysis of randomized controlled trials’, Frontiers in Nutrition, 11. Available at: https://doi.org/10.3389/fnut.2024.1516086.
Systematic Reviews, Meta-Analyses and other reviews
Trials/Studies
Yancy WS, Westman EC, McDuffie JR, et al. A Randomized Trial of a Low-Carbohydrate Diet vs Orlistat Plus a Low-Fat Diet for Weight Loss. Arch Intern Med. 2010;170(2):136. doi:10.1001/archinternmed.2009.492
Chiu S, Bergeron N, Williams PT, Bray GA, Sutherland B, Krauss RM. Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial1–3. The American Journal of Clinical Nutrition. 2016;103(2):341-347. doi:10.3945/ajcn.115.123281Unwin DJ, T
Unwin DJ, Tobin SD, Murray SW, Delon C, Brady AJ. Substantial and Sustained Improvements in Blood Pressure, Weight and Lipid Profiles from a Carbohydrate Restricted Diet: An Observational Study of Insulin Resistant Patients in Primary Care. International Journal of Environmental Research and Public Health. 2019;16(15):2680. doi:10.3390/ijerph16152680
Association Studies
Fasting
Mechanisms
Chirapongsathorn, S. et al. (2025) ‘Effect of a Ketogenic Diet on Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial’, JGH Open: An Open Access Journal of Gastroenterology and Hepatology, 9(1), p. e70099. Available at: https://doi.org/10.1002/jgh3.70099.
Khalafi, M. et al. (2025) ‘Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis’, Nutrition & Metabolism, 22(1), p. 1. Available at: https://doi.org/10.1186/s12986-024-00885-x.
Wang, Y. et al. (2024) ‘Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease—a randomized controlled trial’, Frontiers in Nutrition, 11. Available at: https://doi.org/10.3389/fnut.2024.1439473.
Li, D., Dawson, J. and Gunton, J.E. (2025) ‘Therapeutic Potential of Ketogenic Interventions for Autosomal-Dominant Polycystic Kidney Disease: A Systematic Review’, Nutrients, 17(1), p. 145. Available at: https://doi.org/10.3390/nu17010145.
Xiao, X. and Li, Z. (2025) ‘The Potential of Dietary Strategies: The Impact of Low-Carbohydrate Diet on Cardiovascular-Kidney-Metabolic Syndrome’. medRxiv, p. 2025.01.03.25319951. Available at: https://doi.org/10.1101/2025.01.03.25319951. PDF
Pezzuoli, C., Biagini, G. and Magistroni, R. (2024) Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence. Available at: https://doi.org/10.20944/preprints202407.0919.v1. (preprint)
Annunziata, G. et al. (2024) ‘Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from [Italian groups]’, Journal of Endocrinological Investigation [Preprint]. Available at: https://doi.org/10.1007/s40618-024-02446-8.
Trapanese, V. et al. (2024) ‘Impressive weight loss induced by a very low-calorie ketogenic diet in a morbidly complex obese patient with a recent episode of acute kidney injury and advanced chronic kidney disease: a case report’, Italian Journal of Medicine, 18(3). Available at: https://doi.org/10.4081/itjm.2024.1787.
Muensterman, E.G. et al. (2024) ‘Real-Life Data from a Ketogenic Metabolic Therapy Program for Autosomal-Dominant Polycystic Kidney Disease Suggests Significant Benefits to Participants: TH-PO440’, Journal of the American Society of Nephrology, 35(10S), p. 10.1681/ASN.2024kqy7mws6. Available at: https://doi.org/10.1681/ASN.2024kqy7mws6.
Torres, J.A. et al. (2024) ‘“β-Hydroxybutyrate Recapitulates the Beneficial Effects of Ketogenic Metabolic Therapy in Polycystic Kidney Disease”’, iScience, p. 110773. Available at: https://doi.org/10.1016/j.isci.2024.110773.
Pasca, L. et al. (2023) ‘Ketonemia variability through menstrual cycle in patients undergoing classic ketogenic diet’, Frontiers in Nutrition, 10. Available at: https://www.frontiersin.org/articles/10.3389/fnut.2023.1188055.
Systematic Reviews, Meta-analyses & Narrative Reviews
Trials/Studies
Lactation
Caution – there are several reports of lactation ketoacidosis occuring in the literature (see Possible Complications). For a prudent interpretation of the literature regarding breastfeeding, the link below to Dr. Andreas Eenfeldt – Diet Doctor, may be helpful – Breastfeeding on a low-carb diet – is it dangerous? Diet Doctor.
As oestrogen/progesterone are insulin sensitizing hormones, a reduction in these hormones can increase insulin resistance which may contribute to the metabolic dysregulation and symptoms of menopause. This section includes studies that support potential benefits of a TCR approach to help manage areas of common concern during menopause, primarily as a means of reducing glycaemic variability and insulin resistance.
Insulin resistance, weight gain and cardiovascular disease
Therapeutic carbohydrate reduction is one way to combat insulin resistance, weight gain, and inflammation – risk factors for CVD. Insulin resistance also contributes to platelet dysfunction and clotting risk.
For more on this see CVD, obesity, and insulin resistance sections.
Glycaemic variability, insulin resistance and hot flashes
In addition to reducing hyperinsulinaemia, a TCR approach reduces glycaemic variability – keeping blood sugars more stable and can successfully reduce abdominal adiposity.
Sleep
Sleep has a bidirectional effect on metabolic health. Poor sleep patterns, such as shift work, can increase insulin resistance and increase the risk of developing metabolic syndrome. Increasing insulin resistance via other mechanisms, like changes in hormones, can reduce melatonin (inverse relationship) and affect sleep.
For more on this, see section on sleep.
Brain glucose hypometabolism and cognitive decline
‘The peri-menopausal transition is a tipping point for female brain aging. From the metabolic perspective, the process begins with decline in glucose metabolism and increase in insulin resistance, followed by a compensatory mechanism to use fatty acids and ketone bodies as an auxiliary fuel source’ Wang et al
TCR reduces brain insulin resistance and inflammation. If carbohydrate intake is sufficiently reduced ketone bodies can provide an alternative fuel source for the brain, further supporting cognitive function.
For more on this, see section on Neurodegeneration.
Insulin resistance and mental health
This is an emerging area. See the section on Mental Health for the full collection.
Insulin resistance and bone turnover
Diet quality affects bone markers and metabolic syndrome is associated with reduced bone mineral density therefore addressing metabolic health through diet may have a valid role in protection from osteoporosis.
For more on this, see section on bone health.
Breast Cancer and Insulin Resistance
Multiple factors contribute to increased risk of breast cancer – the presence of insulin resistance/metabolic syndrome is known to impact risk and prognosis. For more on this, see section on cancer.
This review from Calkins et al., 2024 is an important read that informs on reduced carbohydrate approaches in young people ‘Carbohydrate reduction for metabolic disease is distinct from the ketogenic diet for epilepsy’.
Chakraborty, S. et al. (2025) ‘A very low carbohydrate diet improved metabolic profile in congenital generalized lipodystrophy type 4’. Available at: https://doi.org/10.1530/EDM-24-0063.
Rodrigue C, Iceta S, Bégin C. Food Addiction and Cognitive Functioning: What Happens in Adolescents? Nutrients. 2020;12(12):3633. doi:10.3390/nu12123633 (added for completeness – for more on this complex and emerging area see Food Addiction and Binge Eating Disorder Spectrum)
Rohani, P. et al. (2024) ‘Effect of a carbohydrate-restricted diet on weight loss in overweight and obese pediatric population: a meta-analysis of randomized controlled trials’, Diabetology & Metabolic Syndrome, 16(1), p. 210. Available at: https://doi.org/10.1186/s13098-024-01458-x.
Zhang, Y. et al. (2024) ‘Low-Carbohydrate Diet is More Helpful for Weight Loss Than Low-Fat Diet in Adolescents with Overweight and Obesity: A Systematic Review and Meta-Analysis’, Diabetes, Metabolic Syndrome and Obesity, Volume 17, pp. 2997–3007. Available at: https://doi.org/10.2147/DMSO.S467719.
Neuman, V. et al. (2024) ‘Low-carbohydrate diet in children and young people with type 1 diabetes: A randomized controlled trial with cross-over design’, Diabetes Research and Clinical Practice, 217, p. 111844. Available at: https://doi.org/10.1016/j.diabres.2024.111844
Levran, N. et al. (2024) ‘Low-carbohydrate diet proved effective and safe for youths with type 1 diabetes: A randomised trial’, Acta Paediatrica (Oslo, Norway: 1992) [Preprint]. Available at: https://doi.org/10.1111/apa.17455.
Launching 8 March – Open for sign-up NOW!
14-Day Money-Back Guarantee